Gent - 05 November 2008 - Devgen (EBR:DEVG) Announces The Intention To Close Its Pharma Division And To Fully Focus On The Development Of Its Agro Business.
Devgen (EBR:DEVG) In November 2007, Devgen announced its intent to divest its pharma unit in order to focus on its agro-activities. Through its research activities in Belgium, Devgen has developed a unique technology position in crop protection and has grown to a fully integrated trait and seed business in Asian growth markets, with a focus on rice, sorghum, sunflower and pearl millet and a licensing business in other crops. Devgen's pharma division focuses on the development of a novel class of preclinical drug candidates for the treatment of inflammatory diseases.
